Video: Does remdesivir work for COVID-19?

Credit: CC0 Public Domain

The first double-blind, randomized, placebo-controlled study was published in the New England Journal of Medicine. The researchers discovered that patients treated with the drug were on average sick for less time – an average of 11 days versus 15.

They also found some evidence that the drug appeared to slightly reduce severity of the disease, and to slightly reduce the . There was no indication that Remdesivir could be used to completely cure COIVD-19. More studies are needed to determine effective dosing strategies to reduce severity and duration of illness, and to better understand the impact of the on different kinds of patients.

Credit: Pennsylvania State University
Journal information: New England Journal of Medicine

Citation: Video: Does remdesivir work for COVID-19? (2020, June 16) retrieved 10 December 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors